Adding abiraterone acetate plus prednisolone (AAP) or docetaxel for patients (pts) with high-risk prostate cancer (PCa) starting long-term androgen deprivation therapy (ADT): Directly randomised data from STAMPEDE (NCT00268476)

作者:Sydes M R; Mason M D; Spears M R; Clarke N W; Dearnaley D; Ritchie A W S; Russell M; Gilson C; Jones R; de Bono J; Gillessen S; Millman R; Tolan S; Wagstaff J; Chowdhury S; Lester J; Sheehan D; Gale J; Parmar M K; James N D
来源:42nd European-Society-for-Medical-Oncology Congress (ESMO), 2017-09-08 to 2017-09-12.
  • 出版日期2017-9